SupplementSupplement

Take a look back at the top ovarian cancer news from 2019

In this supplement to HemOnc Today, we have compiled the most-read articles written about ovarian cancer this year.
From risk reducing measures (click here) to improving progression-free survival (click here and here), our experts researched and weighed in on the spectrum of this deadly carcinoma.
“These are exciting times in ovarian cancer research and, more importantly, for patients. Recent discoveries have realized the possibility that this is the beginning of the end of ovarian cancer,” Michael J. Birrer, MD, PhD, writes in his editorial (click here). “Our new understanding of the origins of this disease may give rise to a reasonably effective early detection assay, which remains the holy grail of ovarian cancer research.”
To follow along this journey, be sure to follow @HemOncToday on Twitter and visit Healio.com regularly.

Click here to view the interactive PDF and visit the Gynecologic Cancer newsfeed for the latest news in ovarian cancer.

Cover sup

In this supplement to HemOnc Today, we have compiled the most-read articles written about ovarian cancer this year.
From risk reducing measures (click here) to improving progression-free survival (click here and here), our experts researched and weighed in on the spectrum of this deadly carcinoma.
“These are exciting times in ovarian cancer research and, more importantly, for patients. Recent discoveries have realized the possibility that this is the beginning of the end of ovarian cancer,” Michael J. Birrer, MD, PhD, writes in his editorial (click here). “Our new understanding of the origins of this disease may give rise to a reasonably effective early detection assay, which remains the holy grail of ovarian cancer research.”
To follow along this journey, be sure to follow @HemOncToday on Twitter and visit Healio.com regularly.

Click here to view the interactive PDF and visit the Gynecologic Cancer newsfeed for the latest news in ovarian cancer.

Cover sup